Offer - Urjas Oil for just ₹ 1 X
Rasagin 0.5 Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Parkinson's Disease.
The optimal dosage of Rasagin 0.5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Rasagin 0.5 Tablet side effects, there are can be others also. These have been listed below. These side effects of Rasagin 0.5 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Rasagin 0.5 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. It is important to know if Rasagin 0.5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rasagin 0.5 Tablet related warnings section.
Rasagin 0.5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Psychosis, Low Blood Pressure (Hypotension) are examples of such conditions. Other contraindications of Rasagin 0.5 Tablet have been discussed in the sections ahead.
Drug reaction of Rasagin 0.5 Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Rasagin 0.5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Rasagin 0.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rasagin 0.5 Tablet safe for pregnant women?
Rasagin can have harmful effects in pregnant women. If you experience any discomfort after using Rasagin, then discontinue the use and take your doctor's advice.
Is the use of Rasagin 0.5 Tablet safe during breastfeeding?
Taking Rasagin may lead to serious side effects if you are breastfeeding. Rasagin should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Rasagin 0.5 Tablet on the Kidneys?
Rasagin may have mild side effects on the kidneys.
What is the effect of Rasagin 0.5 Tablet on the Liver?
Rasagin is rarely harmful for the liver.
What is the effect of Rasagin 0.5 Tablet on the Heart?
Using Rasagin does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Rasagin 0.5 Tablet unless your doctor advises you to do so -
Is this Rasagin 0.5 Tablet habit forming or addictive?
Rasagin 0.5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rasagin 0.5 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Rasagin 0.5 Tablet is safe as it does not bear any side effects.
Is it able to treat mental disorders?
Yes, in many cases, taking Rasagin 0.5 Tablet can help with mental disorders.
Interaction between Food and Rasagin 0.5 Tablet
Eating certain foods may increase the time it takes Rasagin 0.5 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Rasagin 0.5 Tablet
Taking alcohol with Rasagin 0.5 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azilect (rasagiline mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 432
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1085-1086